By R. Kirk Huntsman

Obstructive sleep apnea (OSA) is a widespread but often overlooked condition, characterized by repeated interruptions in breathing during sleep. Despite affecting approximately 80 million adults in the U.S., an estimated 80% of cases go undiagnosed. Its impact extends far beyond disrupted rest, posing serious risks to cardiovascular health, cognitive function, and overall well-being.

For healthcare professionals, OSA represents a critical public health challenge. This widespread underdiagnosis not only compromises individual health but also contributes to an economic burden of $149.6 billion annually, driven by increased healthcare utilization, motor vehicles and workplace accidents, and lost productivity.

Traditional treatments like positive airway pressure (PAP) therapy and surgical interventions, while effective, often face patient adherence issues due to comfort and convenience concerns. Emerging non-invasive, non-surgical devices are now transforming the management of OSA. These innovative solutions provide healthcare providers, technology buyers, and decision-makers with tools that enhance patient outcomes while addressing barriers to treatment adherence.

Challenges with current treatments for OSA
Continuous positive airway pressure (CPAP) machines have long been the standard in managing obstructive sleep apnea (OSA), delivering a constant flow of air through a mask to keep airways open during sleep. However, patient adherence remains a significant challenge, with many finding the masks uncomfortable and the noise disruptive. Studies estimate that approximately 20% of OSA patients discontinue CPAP use over time, often due to a lack of perceived benefit, leaving a substantial portion untreated. These challenges underscore the critical need for alternative solutions that combine clinical efficacy with improved patient comfort and satisfaction.

Mandibular advancement devices (MADs), which resemble custom-fitted mouthguards, offer a less intrusive alternative. These devices reposition the jaw to help prevent airway obstruction. While suitable for some patients, MADs often cause discomfort, such as jaw pain, and are not always effective for individuals with moderate to severe OSA.

Surgical interventions, ranging from tissue removal to implantable devices that stimulate airway muscles, present another option. While often effective, these procedures are invasive, carry inherent risks, and require significant recovery time, making them less appealing for many patients.

Business Affairs Homepage